Bacteroides eggerthii

What was studied?

This study examined whether gut microbiome composition and microbial metabolite profiles differ between lean and obese youth with type 1 diabetes (T1D). Researchers used metagenomic shotgun sequencing of stool samples to characterize bacterial community structure and taxa abundance. They also measured short-chain fatty acids (SCFAs) as microbial metabolite outputs. The goal was to describe obesity-associated gut microbial changes in a T1D population, a group already at elevated risk for complications.

Who was studied?

The pilot study included T1D youth divided into a lean group (BMI 5th to under 85th percentile, n = 27) and an obese group (BMI at or above the 95th percentile, n = 21). Participants had a mean age of 15.3 years, mean glycated hemoglobin A1c of 7.8%, and mean diabetes duration of 5.1 years. The combined sample was 42.0% female and 94.0% White.

What were the most important findings?

Bacterial community composition (beta-diversity) differed significantly between BMI groups. The obese group showed a significantly higher ratio of Prevotella to Bacteroides and increased relative abundance of Prevotella copri, along with other taxa that differed between lean and obese groups. Functional profiling also revealed upregulation of branched-chain amino acid (BCAA) biosynthesis pathways in the obese group, pointing to a metabolic signature accompanying the taxonomic shifts.

What are the greatest implications of this study?

These findings suggest that obesity in T1D youth is accompanied by measurable, structured changes in gut microbial ecology and function, not just body composition differences. The Prevotella to Bacteroides shift and BCAA biosynthesis upregulation echo patterns reported in obesity research more broadly, raising the possibility of shared microbial mechanisms across metabolic conditions. Because this was a pilot study, the findings support further investigation into the gut microbiome as a potential contributor to, or biomarker for, obesity-related complications in T1D.

What was studied?

This study characterized the gut microbiota of patients with natural killer/T-cell lymphoma (NKTCL), an aggressive malignancy with a poor prognosis, using shotgun metagenomic sequencing. The researchers aimed to identify marker species linked to disease outcomes and to test whether specific gut bacteria could act as probiotics to slow NKTCL progression. They combined cross-sectional microbiota profiling with in vivo and in vitro tumor models, plus metabolomics, RNA sequencing, chromatin immunoprecipitation sequencing, Western blot, immunohistochemistry, and gene knockdown experiments to trace the underlying mechanism.

Who was studied?

The study drew on two Chinese cohorts of NKTCL patients, with findings validated in an independent Korean cohort. Cox proportional hazards models were used to relate microbial marker species to patient survival outcomes across these cohorts. Beyond the human cohorts, the mechanistic work relied on in vivo and in vitro tumor models rather than additional patient populations.

What were the most important findings?

NKTCL patients showed marked gut microbiota dysbiosis, most notably a reduction in Faecalibacterium prausnitzii, a butyrate-producing commensal. This depletion correlated strongly with shorter patient survival. The abstract further indicates that F. prausnitzii demonstrated antitumour properties against NKTCL, with the fuller mechanistic work pointing toward suppression of the JAK-STAT pathway as noted in the study title.

What are the greatest implications of this study?

The findings position F. prausnitzii, a butyrate-producing anti-inflammatory commensal, as a potential prognostic marker and probiotic candidate in NKTCL, a cancer with few therapeutic levers. Restoring this depleted organism could represent a novel adjunct strategy to dampen tumor-promoting JAK-STAT signaling. These results support further investigation into microbiome-targeted interventions for aggressive lymphomas where gut dysbiosis tracks with clinical outcomes.

What was studied?

Inflammation and innate immune activation are associated with chronic HIV infection, despite effective treatment. Although gut microbiota alterations are linked to systemic inflammation, the relationships between the gut microbiome, inflammation and HIV remain unclear.

Who was studied?

The UPBEAT-CAD sub-study, examining cardiovascular disease (CVD) risk in HIV, enrolled participants matched on HIV status and traditional CVD risk factors. Subclinical CVD was assessed using coronary computed tomography angiography (CCTA). 34 biomarkers were measured using quantitative immunoassays. Microbiota composition was analysed by 16S rRNA sequencing of stool samples, with taxonomic assignment via the SPINGO pipeline. Differentially abundant species were identified by Analysis of Compositions of Microbiomes with Bias Correction (ANCOM-BC) and correlated to biomarkers, diet and CCTA outcomes using Spearman correlation.

What were the most important findings?

Among 81 participants (median age 51 years, 73% male), people with HIV (n=44 , 54%) had a higher prevalence of hypercholesterolaemia (p <0.025) and statin use (p <0.001). A significant separation in gut microbiome β-diversity was observed between people with and without HIV. ANCOM-BC analysis identified 42 differentially abundant species and 10 genera in those with HIV. Enrichment of Bifidobacterium pseudocatenulatum, Megamonas hypermegale and Selenomonas ruminantium and depletion of Fusicatenenibacter correlated with lower plaque burden. Depletion of SCFA-producing Ruminococcus bromii correlated with higher plaque burden and fat intake, while depletion of Bacteroides spp and Alistepes spp correlated with elevated inflammatory biomarkers (D-dimer, CD40-ligand, CRP and IFN-γ).

What are the greatest implications of this study?

Significant gut microbiota differences in people with HIV were linked to subclinical CVD, diet, and inflammation, suggesting a role for the microbiome in cardiovascular risk in HIV infection.

What was studied?

Species in the family Canidae occupy different spatial ecological niches, and some (e.g., wolf) can be kept in zoos. The gut microbiome may differ among various wild and captive canids. Therefore, we compared the gut microbiomes of wild canids (wolf, red fox, and corsac fox) in the Hulun Lake area, captive wolves, and domestic dogs in different regions using metagenomic data. A random forest analysis revealed significant enrichment for bacterial species producing short-chain fatty acids and the thermogenesis pathway (ko04714) in the gut microbiome of wild wolf, potentially providing sufficient energy for adaptation to a wide range of spatial ecological niches. The significantly enriched bacterial species and functional pathways in the gut microbiome of corsac foxes were related to physiological stability and adaptation to arid environments. Alpha diversity of carbohydrate-active enzymes in the gut microbiome was higher in the red fox than in the corsac fox and wild wolf, which may be related to the abundance of plant seeds (containing carbohydrates) in their diets (red foxes inhabit seed-rich willow bosk habitats). However, the influence of host genetic factors cannot be excluded, and further experimental studies are needed to verify the study results. In addition, captive environments drove similarity in carbohydrate-active enzymes (CAZymes) and virulence factors (VFs) in the gut microbiomes of captive wolf and domestic dog, and increased the diversity of CAZymes and VFs in the gut microbiome of captive wolf. Increased VFs diversity may increase the pathogenic potential of the gut microbiome in captive wolves. Therefore, it is necessary to continue monitoring the health status of captive wolves and develop appropriate management strategies.

What was studied?

Previous case-control studies have reported aberrations of the gut microbiota in individuals with prediabetes. The primary objective of the present study was to explore the dynamics of the gut microbiota of individuals with prediabetes over 4 years with a secondary aim of relating microbiota dynamics to temporal changes of metabolic phenotypes.

Who was studied?

The study included 486 European patients with prediabetes. Gut microbiota profiling was conducted using shotgun metagenomic sequencing and the same bioinformatics pipelines at study baseline and after 4 years. The same phenotyping protocols and core laboratory analyses were applied at the two timepoints. Phenotyping included anthropometrics and measurement of fasting plasma glucose and insulin levels, mean plasma glucose and insulin under an oral glucose tolerance test (OGTT), 2-h plasma glucose after an OGTT, oral glucose insulin sensitivity index, Matsuda insulin sensitivity index, body mass index, waist circumference, and systolic and diastolic blood pressure. Measures of the dynamics of bacterial microbiota were related to concomitant changes in markers of host metabolism.

What were the most important findings?

Over 4 years, significant declines in richness were observed in gut bacterial and viral species and microbial pathways accompanied by significant changes in the relative abundance and the genetic composition of multiple bacterial species. Additionally, bacterial-viral interactions diminished over time. Despite the overall reduction in bacterial richness and microbial pathway richness, 80 dominant core bacterial species and 78 core microbial pathways were identified at both timepoints in 99% of the individuals, representing a resilient component of the gut microbiota. Over the same period, individuals with prediabetes exhibited a significant increase in glycemia and insulinemia alongside a significant decline in insulin sensitivity. Estimates of the gut bacterial microbiota dynamics were significantly correlated with temporal impairments in host metabolic health.

What are the greatest implications of this study?

In this 4-year prospective study of European patients with prediabetes, the gut microbiota exhibited major changes in taxonomic composition, bacterial species genetics, and microbial functional potentials, many of which paralleled an aggravation of host metabolism. Whether the temporal gut microbiota changes represent an adaptation to the progression of metabolic abnormalities or actively contribute to these in prediabetes cases remains unsettled.

What was studied?

The gut microbiota is a complex microbial ecosystem with a major impact on health and disease. Some gut unicellular eukaryotes (particularly Blastocystis) have been linked to features of intestinal eubiosis. Meanwhile, little is known regarding associations between gut-pathogenic protozoa, such as Giardia, and gut microbiota signatures. We therefore characterized and compared gut microbiota profiles of 60 Giardia-positive and 31 Giardia-negative Algerian individuals using amplicon-based next-generation sequencing of prokaryotic and eukaryotic ribosomal genes and stratifying for co-colonization with other unicellular eukaryotes, such as species of Archamoebae or Blastocystis. Overall, we found that alpha and beta microbiota diversity did not differ significantly between Giardia-positive and Giardia-negative individuals, regardless of the presence or absence of Archamoebae and Entamoeba (p > 0.05). However, significant differences were observed in both alpha and beta diversity between Giardia-positive, Blastocystis-negative and Giardia-positive, Blastocystis-positive individuals (observed richness, p = 0.0016; ANOSIM = 0.001), and similar differences were noticed between Blastocystis-negative and-positive carriers (p < 0.05), regardless of Giardia carrier status. Importantly, these differences in gut microbiota were considered to be independent of factors such as sex, age, and location (p > 0.05). Conclusively, Giardia-positive individuals may exhibit features of eubiosis, but whether this depends on the presence of Blastocystis should be confirmed by future studies. These findings combined might indicate that Blastocystis could be an active driver of gut microbiota diversity.

What was studied?

This study examined whether rifaximin, a gut-specific non-absorbable antibiotic, could reduce gut-derived systemic inflammation in severe acute pancreatitis (SAP). The researchers combined murine experimental models with a single-center, open-label randomized controlled trial (ChiCTR2100049794). They assessed pancreatic injury, systemic inflammatory markers, and gut microbiota composition, and tested whether rifaximin's effects depended on modulating the microbiota by using antibiotic-treated and germ-free mice.

Who was studied?

The animal component used murine models of severe acute pancreatitis, including antibiotic-treated and germ-free mice used to probe the mechanism. The clinical component enrolled 60 patients with predicted severe acute pancreatitis, randomized to receive rifaximin or standard control treatment. No further demographic details are given in the abstract.

What were the most important findings?

In mice, rifaximin reduced pancreatic injury and systemic inflammation and decreased mucin-degrading gut genera such as Akkermansia, but its protective effects persisted even in antibiotic-treated and germ-free mice, indicating mechanisms beyond microbiota modulation. In patients, rifaximin significantly lowered systemic inflammation, with white blood cell count falling from a median of 11.50 x10^9/L to 8.49 x10^9/L and TNF-alpha falling from 15.05 pg/mL to 11.00 pg/mL. However, the rate of culture-confirmed infection was identical between rifaximin and control groups (13.3% vs 13.3%), and adverse events were comparable between groups.

What are the greatest implications of this study?

The findings suggest rifaximin can dampen systemic inflammation in severe acute pancreatitis through mechanisms that are not solely dependent on reshaping the gut microbiota, pointing to a possible direct anti-inflammatory or barrier-protective effect. Because inflammation markers improved without any change in infection risk, rifaximin may offer a safe adjunct for controlling inflammatory injury in SAP without added infectious risk. This supports further investigation of rifaximin as a therapeutic strategy for gut-derived inflammation in acute pancreatitis, alongside continued study of its non-microbiota-dependent mechanisms.

What was studied?

Colorectal cancer (CRC) is a significant global health burden, ranking amongst the top causes of cancer-associated mortality. Emerging evidences implicate gut microbiota as a prominent mediator of cell signalling, immune, and metabolic pathways in the pathophysiology of CRC.

Who was studied?

We analysed 16S rRNA amplicon sequencing data (PRJEB7774) from faecal samples of 46 CRC patients and 63 healthy controls to assess shifts in microbial composition, diversity, and biomarker taxa. Differential abundances of microbiota were determined using Linear Discriminant Analysis Effect Size (LEfSe) and Random Forest (RF) models. Host-microbiota interactions were explored using the Human Microbiome Affect the Host Epigenome (MIAOME) and Host Genetic and Immune Factors Shaping Human Microbiota (GIMICA) databases, with key host genes validated using Gene Expression Profiling Interactive Analysis (GEPIA) and The Cancer Genome Atlas (TCGA) datasets. Functional enrichment analyses were performed to uncover associated biological processes and pathways.

What were the most important findings?

CRC samples exhibited significantly reduced alpha diversity and distinct beta diversity profiles, compared to controls. Taxonomic profiling revealed an enrichment of potentially pathogenic bacteria, including Prevotella copri, Methanobrevibacter smithii, Bacteroides eggerthii, and Dialister invisus, and depletion of beneficial microbes such as Bifidobacterium animalis and Ruminococcus sp. Predicted host-microbe interactions highlighted associations between key microbial biomarkers and inflammation-related genes (CD44, CXCL8, DUSP16, FOXP3, IFNGR2, IL18), all significantly overexpressed in CRC samples. Enrichment analyses linked these genes to immune pathways, including NF-κB, TLR and cytokine signalling.

What are the greatest implications of this study?

Our study reveals a distinct gut microbiota signature in CRC and suggests functional interactions between microbial dysbiosis and host inflammatory responses. These findings emphasize the potential of microbiota-based interventions and microbial metabolites as adjunctive strategies for the management of CRC.

What was studied?

This study examined how the gut microbiome changes across a rural-to-urban lifestyle transition in Indonesia. The researchers assembled metagenome-assembled genomes to characterize species and subspecies diversity within these communities. They also investigated how bacterial physiology, specifically sporulation capacity, relates to how widespread or restricted a given microbial taxon is across villages. Finally, they assessed whether diet variation between communities versus within communities better predicts overall microbiome composition.

Who was studied?

The dataset comes from 116 Indonesians whose lifestyles span transitional hunter-gatherer, rural agricultural, and urban populations. This sampling directly addresses a gap in microbiome research, since existing datasets are heavily biased toward Western urban cohorts and Southeast Asia has been especially under-represented. From these 116 individuals, the team assembled 11,070 metagenome-assembled genomes for analysis.

What were the most important findings?

The researchers identified 1,304 species and 3,258 subspecies, revealing substantial novelty at both the species level (15%) and the subspecies level (50%). Novel taxa tended to be rare, often specific to a single village, and depleted in sporulation genes, linking bacterial physiology to transmission patterns, prevalence, and the likelihood of prior discovery. Clear rural-to-urban clines emerged across multiple levels of biological organization, from individual species abundance to overall microbiome composition and diversity. Diet variation between communities, but not variation within a community, strongly predicted microbiome composition.

What are the greatest implications of this study?

The findings suggest that microbiome divergence across lifestyles is shaped primarily by community-level factors rather than individual-level differences in diet. The link between sporulation genes and village-specific, rarely detected taxa highlights how bacterial physiology influences transmission and the chances a species has been previously characterized. This work underscores the need to expand microbiome sampling beyond Western urban populations to capture the full scope of human microbiome diversity and biogeography. It also demonstrates that lifestyle transition, population structure, and bacterial physiology jointly shape microbiome variation at the scale of human communities.

What was studied?

This study investigated how the gut microbiota influences differential host resistance to porcine epidemic diarrhea virus (PEDV) infection in piglets. Researchers combined single-cell transcriptomics, 16S amplicon sequencing, metagenomics, and untargeted metabolomics to characterize the microbial and metabolic changes that follow PEDV infection. The work focused on identifying specific bacterial species and their metabolites that mediate protection against this pathogen.

Who was studied?

The study used Landrace and Min pig breeds, two breeds with differing natural resistance to PEDV infection. Landrace pigs, which lose resistance quickly after infection, received fecal microbiota transplants from Min pigs, which are comparatively resistant. Animal protection models were then used to test the effects of specific bacteria and metabolites identified through the multi-omics analysis.

What were the most important findings?

PEDV infection caused significant changes in the gut microbiota of piglets, and transplanting fecal microbiota from resistant Min pigs into susceptible Landrace pigs alleviated the infection. Metagenomic and animal protection models identified Lactobacillus reuteri and Lactobacillus amylovorus as playing an anti-infective role. Metabolomic screening linked these bacteria to the secondary bile acids deoxycholic acid (DCA) and lithocithocholic acid (LCA), but only LCA showed a protective effect in the animal model, and LCA supplementation altered the distribution of intestinal T-cell populations, notably enriching CD8+ populations.

What are the greatest implications of this study?

These findings identify lithocholic acid as a key gut microbiota-derived metabolite mediating protection against PEDV infection in piglets. The results point to Lactobacillus reuteri and Lactobacillus amylovorus as candidate probiotic strains that could be harnessed to boost disease resistance through bile acid metabolism. This work suggests that modulating the gut microbiota and its bile acid metabolites, particularly LCA, and their effects on intestinal T-cell populations, could be a strategy for improving resistance to enteric viral pathogens in livestock.

What was studied?

This study examined whether the gut and pharyngeal microbiome is associated with tuberculosis (TB) disease stages. Researchers used full-length 16S rDNA amplicon sequencing performed with Oxford Nanopore Technologies to profile bacterial communities. The comparison spanned TB-negative controls, latent TB, and active TB groups. The goal was to identify microbial differences that track with TB progression from latent to active disease.

Who was studied?

The subjects were 71 cynomolgus macaques, an animal model used to study TB pathogenesis. The macaques were divided into three groups: TB (-) control, TB (+) latent, and TB (+) active. No human cohort was involved, so findings reflect a non-human primate model rather than a human population.

What were the most important findings?

In the pharyngeal microbiome, Haemophilus hemolyticus was decreased and Prevotella species were increased in TB (+) macaques compared to controls. In the gut microbiome, Eubacterium coprostanoligenes was enriched in TB (+) macaques. These shifts distinguished infected animals from TB-negative controls, suggesting that specific taxa track with TB status in both the pharynx and the gut.

What are the greatest implications of this study?

The findings suggest that alterations in gut and pharyngeal bacteria may influence host immune regulation and TB severity, though the underlying mechanisms still need to be explored and validated. This work points to potential host-microbe interactions relevant to TB progression that could inform future understanding of disease biology. It also raises the possibility that microbiome-based markers or targets could eventually contribute to TB therapeutics, pending further mechanistic and translational research.

What was studied?

This study examined the relationship between the gut microbiome and the host genome and transcriptome in colorectal cancer (CRC). Researchers profiled the fecal microbiome structure alongside genomic and transcriptomic data from matched tumor and normal mucosa tissue. Exome sequencing was used to identify somatic mutations, and gene expression patterns were annotated and clustered against microbial abundance data. Immune and stromal cell composition was also estimated from the transcriptomic profiles.

Who was studied?

The cohort consisted of 41 patients with colorectal cancer. For each patient, matched tumor tissue and normal mucosa tissue were analyzed alongside fecal microbiome samples. The abstract does not provide further demographic details such as age, sex, or geographic origin of the participants.

What were the most important findings?

The researchers identified 22 gut microbial species significantly associated with CRC and estimated relative abundance across functional (KEGG) pathway categories. Four significantly mutated genes, TP53, APC, KRAS, and SMAD4, were linked to specific cancer-associated microbes. Fusobacterium nucleatum in particular showed a positive correlation with multiple host metabolic pathways, tying a specific pathogen to altered tumor metabolism. The abstract text is truncated before further results are described.

What are the greatest implications of this study?

The findings support a functional link between specific gut bacteria, such as Fusobacterium nucleatum, and the somatic mutation landscape and metabolic activity of colorectal tumors. This multi-omic approach suggests that microbial taxa may interact with host driver mutations like TP53, APC, KRAS, and SMAD4 rather than merely coexisting with the tumor. Such associations could inform future work on microbiome-informed risk stratification or targets in CRC, though the abstract does not describe therapeutic testing or outcomes.

What was studied?

Polycystic ovary syndrome (PCOS) is an endocrinopathy in childbearing-age females which can cause many complications, such as diabetes, obesity, and dyslipidemia. The metabolic disorders in patients with PCOS were linked to gut microbial dysbiosis. However, the correlation between the gut microbial community and dyslipidemia in PCOS remains unillustrated. Our study elucidated the different gut microbiota in patients with PCOS and dyslipidemia (PCOS.D) compared to those with only PCOS and healthy women.

What were the most important findings?

In total, 18 patients with PCOS, 16 healthy females, and 18 patients with PCOS.D were enrolled. The 16 S rRNA sequencing in V3-V4 region was utilized for identifying the gut microbiota, which analyzes species annotation, community diversity, and community functions. Our results showed that the β diversity of gut microbiota did not differ significantly among the three groups. Regarding gut microbiota dysbiosis, patients with PCOS showed a decreased abundance of Proteobacteria, and patients with PCOS.D showed an increased abundance of Bacteroidota compared to other groups. With respect to the gut microbial imbalance at genus level, the PCOS.D group showed a higher abundance of Clostridium_sensu_stricto_1 compared to other two groups. Furthermore, the abundances of Faecalibacterium and Holdemanella were lower in the PCOS.D than those in the PCOS group. Several genera, including Faecalibacterium and Holdemanella, were negatively correlated with the lipid profiles. Pseudomonas was negatively correlated with luteinizing hormone levels. Using PICRUSt analysis, the gut microbiota community functions suggested that certain metabolic pathways (e.g., amino acids, glycolysis, and lipid) were altered in PCOS.D patients as compared to those in PCOS patients.

What are the greatest implications of this study?

The gut microbiota characterizations in patients with PCOS.D differ from those in patients with PCOS and controls, and those might also be related to clinical parameters. This may have the potential to become an alternative therapy to regulate the clinical lipid levels of patients with PCOS in the future.

What was studied?

This study examined how environmental, socioeconomic, and health factors relate to gut microbiome composition at both the species and strain level. Researchers used deeply sequenced metagenomic data to identify associations between bacterial species and a range of host phenotypes and situational factors. They also performed a meta-analysis of species-level profiles across multiple datasets to look for consistent patterns, such as links to body mass index.

Who was studied?

The study drew on a community-based cohort of 1,871 people living in 19 isolated villages in the Mesoamerican highlands of western Honduras. This is a non-industrialized, geographically isolated population, a setting the authors note remains uncommon in deep gut microbiome sequencing studies. Additional comparisons were made using species-level profiles from other, unspecified datasets as part of a meta-analysis.

What were the most important findings?

Socioeconomic factors accounted for 51.44% of all associations found between the gut microbiome and human phenotypes, making them the dominant category of influence. Meta-analysis across datasets identified several bacterial species associated with body mass index, consistent with prior research. Incorporating strain-level phylogenetic information changed the overall picture of host-microbiome relationships, especially for factors like household wealth, where wealthier individuals were found to harbor different strains of Eubacterium rectale than less wealthy individuals.

What are the greatest implications of this study?

The findings suggest that socioeconomic circumstances are a major driver of gut microbiome variation, potentially more so than many other individual health factors. The demonstration that strain-level differences (not just species presence) track with wealth indicates that species-level analysis alone can miss biologically meaningful variation. The authors conclude that gut microbiome surveillance in such populations could help illuminate broader patterns relevant to both individual and public health.

What was studied?

This study used whole-genome shotgun sequencing and gas chromatography/mass spectrometry to profile gut microbial and metabolic signatures across seven different malignancies. The researchers compared taxonomic and metabolomic configurations in cancer patients against sex- and age-matched healthy controls. The goal was to identify both common and cancer-type-specific gut microbiome and metabolite alterations.

Who was studied?

The study included patients with colorectal cancer (40), stomach cancer (45), breast cancer (71), lung cancer (34), melanoma (50), lymphoid neoplasms (60), and acute myeloid leukemia (40). Each cancer group was compared against its own sex- and age-matched healthy control group. In total the analysis spanned 300 cancer patients across seven malignancy types plus their matched controls.

What were the most important findings?

Beta-diversity differed between every cancer group and its healthy controls, while alpha-diversity differed only for the lymphoid neoplasm and acute myeloid leukemia groups. Of 203 unique species identified, 179 were under-represented and 24 were over-represented in cancer patients relative to controls. Faecalibacillus intestinalis was under-represented across all seven cancer groups, and Anaerostipes hadrus was under-represented in all groups except stomach cancer, with a marked reduction in the gut microbiome cancer index in every group except acute myeloid leukemia. Among the short-chain fatty acids and amino acids tested, formic acid concentration was significantly altered.

What are the greatest implications of this study?

The consistent depletion of Faecalibacillus intestinalis and altered formic acid levels across seven distinct cancer types suggest these may represent shared, cross-cancer markers of gut dysbiosis rather than disease-specific findings. This points toward a common gut microbial and metabolic signature that could inform future pan-cancer diagnostic or monitoring approaches. Because the pattern held despite differences in cancer biology and location, it strengthens the case for a generalizable link between gut dysbiosis and malignancy.

What was studied?

This study examined whether dietary inulin, a prebiotic fiber, could improve intestinal flora composition and metabolism-related indicators in obese patients with polycystic ovary syndrome (PCOS). PCOS is a common endocrine disorder in women of reproductive age that is closely tied to chronic low-grade inflammation and metabolic disturbance. Because inulin had already shown benefits for gut flora and inflammation in PCOS mouse models, the researchers set out to test whether the same effects would hold in a clinical human population. Patients were followed over three months of inulin treatment, with intestinal flora and metabolic markers measured before and after.

Who was studied?

The study population consisted of obese women with polycystic ovary syndrome compared against healthy controls. The abstract does not give an exact number of participants, so the precise sample size cannot be stated. What can be said honestly is that this was a clinical (human) comparison of PCOS patients versus controls, rather than an animal model, following three months of inulin intervention in the PCOS group.

What were the most important findings?

Dietary inulin improved sex hormone disorders and reduced both BMI and waist-hip ratio (WHR) in obese women with PCOS. The intervention also lowered plasma inflammatory markers, including TNF-alpha, IL-1beta, IL-6, and MCP-1. Gut flora shifted favorably: Actinobacteria, Fusobacteria, Lachnospira, and Bifidobacterium increased, while the Firmicutes/Bacteroidetes ratio and the abundance of Proteobacteria, Sutterella, and Enterobacter decreased. Correlation analyses linked these microbial shifts to changes in plasma inflammatory factors and sex steroid hormones, suggesting the three systems move together.

What are the greatest implications of this study?

The findings suggest that a simple dietary prebiotic, inulin, may offer a low-risk way to address the combined metabolic, hormonal, and inflammatory disturbances seen in obese PCOS patients. Because gut flora changes correlated with both inflammatory and hormonal shifts, the intestinal microbiome may be a mechanistic link connecting diet to PCOS symptoms rather than an incidental bystander. This supports further clinical investigation of inulin or similar fibers as an adjunct therapy for obese women with PCOS, particularly for managing BMI, WHR, and systemic inflammation.

What was studied?

This study examined how exclusive enteral nutrition (EEN), a first-line therapy for pediatric Crohn's disease, produces its protective effects on the gut. The researchers used integrated multi-omics analysis of fecal microbiota and metabolites to identify functional network clusters associated with treatment response. They further validated these diet-driven microbiome changes using gut chemostat cultures and by transferring microbiota into germ-free Il10-deficient mice.

Who was studied?

The abstract describes a prospective pediatric cohort of treatment-naive Crohn's disease patients, registered as German Clinical Trials DRKS00013306, who were followed as they began EEN therapy. Exact patient numbers are not given in the abstract. Findings from this human cohort were then extended experimentally using gnotobiotic (germ-free) Il10-deficient mice colonized with patient-derived microbiota.

What were the most important findings?

Multi-omics analysis identified individually variable microbiome network clusters, with Lachnospiraceae and medium-chain fatty acids emerging as protective features associated with EEN response. Bioorthogonal non-canonical amino acid tagging pinpointed specific bacterial species that responded to medium-chain fatty acids, and metagenomic analysis revealed high strain-level dynamics during EEN therapy. When patient-derived microbiota were transferred into gnotobiotic Il10-deficient mice, individual patient-specific strain signatures could either prevent or cause inflammatory bowel disease-like inflammation.

What are the greatest implications of this study?

The findings show that EEN operates through explicit, functional, and highly individualized changes in the fecal microbiome rather than a single uniform mechanism. Because protective effects were tied to specific strains and metabolites such as medium-chain fatty acids, this suggests that microbiome and metabolite profiling could help predict or enhance EEN response in pediatric Crohn's disease. The demonstration that individual strain signatures can causally prevent or induce inflammation in a gnotobiotic model also supports strain-level and metabolite-targeted approaches as a path toward more precise dietary or microbial therapies for Crohn's disease.

What was studied?

This study examined whether the composition of the oral microbiome is linked to autism spectrum disorder (ASD) and neurodevelopmental outcomes. Researchers used large-scale metagenomic sequencing of saliva samples to test whether microbial community differences could distinguish ASD subjects from neurotypical individuals. They also examined whether microbiome composition correlated with cognitive impairment (measured by IQ) and whether microbial strain sharing between children and parents differed by diagnosis and IQ status. A functional enrichment analysis was performed to identify metabolic pathways that might underlie these differences.

Who was studied?

The study drew on more than 7000 whole-genome sequenced salivary samples from 2025 US families that included children diagnosed with ASD. Each family contributed samples from both an ASD-diagnosed child and a neurotypical sibling (NT), allowing within-family comparisons. This is a large, family-based cross-sectional cohort rather than a small clinical sample.

What were the most important findings?

Oral microbiome composition discriminated ASD children from their neurotypical siblings with an AUC of 0.66, based on 108 differentiating species (q < 0.005). The relative abundance of these species was highly correlated with Full-Scale IQ, and ASD children with IQ below 70 showed significantly lower microbiome strain sharing with their parents than neurotypical children (p < 10-6). Functional enrichment analysis pointed to enzymes involved in serotonin, GABA, and dopamine degradation pathways as contributors to the distinct microbial community differences between ASD and NT samples. Restrictive eating patterns and oral hygiene proxies had only minor effects on these microbiome differences.

What are the greatest implications of this study?

The findings support oral microbiome composition, including neurotransmitter-degradation pathway activity, as a candidate biological marker associated with ASD and its severity as measured by IQ. The reduced strain sharing with parents in lower-IQ ASD children suggests altered microbial transmission or colonization dynamics may track with symptom severity. However, the authors note that causal relationships could not be established, and residual lifestyle differences between groups may still explain part of the association, so these results should be viewed as correlational markers rather than proof of a mechanistic link.

What was studied?

This study examined whether gut microbiome composition differs in people with nontreated plaque psoriasis compared with people without the condition. The researchers used metagenomic gene sequencing of fecal samples to compare microbial taxa and functional gene pathways across groups. They also compared psoriasis patients directly against their own healthy spouses, a design meant to control for shared household and dietary exposures. Gene functional analysis was performed to see whether specific microbial pathways were altered alongside compositional shifts.

Who was studied?

The study included 32 nontreated plaque psoriasis patients, 15 unrelated healthy controls, and 17 healthy spouses of the patients (healthy couples). Fecal samples from these three cohorts were analyzed by metagenomic sequencing. The abstract does not specify age, sex distribution, or geographic origin of participants.

What were the most important findings?

The relative abundance of intestinal microbiota in the psoriasis group differed from both healthy controls and the patients' own healthy partners, though overall microbial diversity was similar across all three groups. At the phylum level, the relative abundances of Firmicutes and Bacteroidetes were reversed in psoriasis patients, and Escherichia coli was significantly enriched compared with both comparison groups. Functional gene analysis showed ribosome pathway genes upregulated, while flagellar assembly and bacterial chemotaxis pathways were downregulated in the psoriasis cohort. Additionally, microbiota composition differed between patients with severe psoriasis and those with milder disease, suggesting a relationship between gut dysbiosis and disease severity.

What are the greatest implications of this study?

These findings strengthen the case for a link between intestinal flora and psoriasis, including a possible relationship between microbial dysbiosis and disease severity. Using patients' own healthy spouses as a comparison group helps address some of the conflicting results in prior psoriasis microbiome research. The authors note that further, more meaningful experiments are needed to clarify the mechanisms underlying this association.

What was studied?

This study investigated the mucosal microbiota at multiple biopsy sites across the spectrum of colorectal cancer (CRC) progression. Researchers used Illumina Miseq sequencing of the 16S rRNA V4 region to profile microbial composition and dynamics in biopsy samples. They also used MinION nanopore sequencing of Fusobacterium-specific amplicons to characterize tumor-associated Fusobacterium nucleatum at the species and subspecies level. The goal was to map how microbial communities shift as tissue progresses from healthy to adenomatous polyp to cancer.

Who was studied?

The abstract describes three groups of biopsy patients from Norway: cancer patients, patients with adenomatous polyps, and healthy controls. Biopsy samples from these groups were sequenced and compared to identify microbiota alterations associated with CRC progression. Fusobacterium-positive tumor biopsies were further subjected to targeted nanopore sequencing. Exact sample sizes for each group are not given in the abstract.

What were the most important findings?

Cancer patients showed enrichment of oral biofilm-associated bacteria compared to adenomatous polyp and control patients, including Fusobacterium, Gemella, Parvimonas, Granulicatella, Leptotrichia, Peptostreptococcus, Campylobacter, Selenomonas, Porphyromonas, and Prevotella. Cancer-associated samples also showed higher abundance of amplicon sequence variants classified as Phascolarctobacterium, Bacteroides vulgatus, Bacteroides plebeius, Bacteroides eggerthii, Tyzzerella, Desulfovibrio, Frisingicoccus, and Eubacterium among others. The presence of Desulfovibrio, a sulfate-reducing bacterial genus capable of producing hydrogen sulfide, was notably elevated alongside these oral pathobionts in cancer tissue. The study further characterized Fusobacterium subspecies within Fusobacterium-positive tumor biopsies using nanopore sequencing.

What are the greatest implications of this study?

These findings support a model in which oral biofilm-associated bacteria, together with sulfate-reducing organisms like Desulfovibrio, colonize and accumulate in colorectal tissue as it progresses toward malignancy. Mapping these site-specific microbial shifts across polyp and cancer stages could help identify microbial markers of CRC progression. Characterizing Fusobacterium at the subspecies level may also refine understanding of which strains are most relevant to tumorigenesis. Together, this work strengthens the rationale for using mucosal microbiota profiles, including sulfide-producing taxa, as part of CRC risk assessment.

What was studied?

Many studies reported the association between gut microbiota and type 2 diabetes mellitus (T2D), but it is still unclear which bacterial genus plays a key role and how the metabolic function of gut microbiota changes in the occurrence and development of T2D. Besides, there is a high diabetic prevalence in Mongolian population, which may be partly affected by their high calorie diet. This study identified the main bacterial genus influencing T2D in Mongolian population, and analyzed the changes of metabolic function of gut microbiome. The association between dietary factors and the relative abundance of main bacterial genus and its metabolic function was also studied.

Who was studied?

Dietary surveys and gut microbiota test were performed on 24 Mongolian volunteers that were divided into T2D (6 cases), PRET2D (6 cases) and Control group (12 cases) according to fasting plasma glucose (FPG) values. The relative abundance and metabolic function of gut microbiome from their fecal samples were measured by metagenomic analysis. Statistic method was used to evaluate the association between dietary factors and the relative abundance of the main bacterial genus or its metabolic function.

What were the most important findings?

This study found that the Clostridium genus may be one of the key bacterial genera affecting the process of T2D. First, the relative abundance of Clostridium genus was significantly different among the three groups. Second, there was a higher relative abundance of metabolic enzymes of gut bacteria in PRET2D and T2D group than that in Control group. Third, a strong correlation between Clostridium genus and many metabolic enzymes was uncovered, many of which may be produced by the Clostridium. Last, carotene intake daily was negatively correlated with the Clostridium but positively correlated with tagaturonate reductase catalyzing interconversions of pentose and glucuronate.

What are the greatest implications of this study?

The gut Clostridium genus may play an important role in the development of T2D and it could be a potential biomarker for T2D in Mongolian population. Meanwhile, the metabolic function of gut bacteria has changed during the early stage of T2D and the changes in carbohydrate, amino acid, lipid or energy metabolism of Clostridium genus may play a critical role. In addition, the carotene intake may affect reproduction and metabolic function of Clostridium genus.

What was studied?

Osteoporosis (OP) is a metabolic bone disorder characterized by low bone mass and deterioration of micro-architectural bone tissue. The most common type of OP is postmenopausal osteoporosis (PMOP), with fragility fractures becoming a global burden for women. Recently, the gut microbiota has been connected to bone metabolism. The aim of this study was to characterize the gut microbiota signatures in PMOP patients and controls. Fecal samples from 21 PMOP patients and 37 controls were collected and analyzed using amplicon sequencing of the V3-V4 regions of the 16S rRNA gene. The bone mineral density (BMD) measurement and laboratory biochemical test were performed on all participants. Two feature selection algorithms, maximal information coefficient (MIC) and XGBoost, were employed to identify the PMOP-related microbial features. Results showed that the composition of gut microbiota changed in PMOP patients, and microbial abundances were more correlated with total hip BMD/T-score than lumbar spine BMD/T-score. Using the MIC and XGBoost methods, we identified a set of PMOP-related microbes; a logistic regression model revealed that two microbial markers (Fusobacteria and Lactobacillaceae) had significant abilities in disease classification between the PMOP and control groups. Taken together, the findings of this study provide new insights into the etiology of OP/PMOP, as well as modulating gut microbiota as a therapeutic target in the diseases. We also highlight the application of feature selection approaches in biological data mining and data analysis, which may improve the research in medical and life sciences.

What was studied?

This study investigated the role of gut microbiota and their metabolites, particularly short-chain fatty acids (SCFAs), in the pathogenesis of functional constipation (FC). The researchers used shotgun metagenomic sequencing of gut microbiota alongside serum SCFA analysis to examine relationships between microbial composition, butyric acid levels, and defecation frequency. They then tested the direct effects of butyrate on intestinal neurons using an in vitro mouse model to explore a possible mechanistic link between microbial butyrate metabolism and enteric nervous system damage.

Who was studied?

The primary cohort consisted of 460 Chinese women with differing defecation frequencies, who underwent shotgun metagenomic sequencing and serum SCFA measurement. Findings were verified in an independent cohort of 6 patients with functional constipation and 6 controls. In addition, mouse intestinal neurons were used in vitro to test the cellular effects of butyrate exposure at concentrations of 0.1, 0.5, 1, and 2.5 mM.

What were the most important findings?

The abundance of Fusobacterium varium, a butyric acid-producing bacterium, was positively correlated with defecation frequency, while serum butyric acid concentration was negatively correlated with defecation frequency. These findings were confirmed in the independent validation cohort. In vitro, intestinal neurons treated with 0.5 mM butyrate proliferated better than neurons exposed to other tested concentrations, with significant differences observed in cell cycle and oxidative phosphorylation signaling pathways.

What are the greatest implications of this study?

The findings suggest that abnormal butyrate metabolism, including altered production by gut bacteria such as Fusobacterium varium and shifts in serum butyrate levels, may damage the enteric nervous system and contribute to functional constipation. This points to butyrate-modulating microbes and serum butyrate concentration as potential biomarkers or targets for understanding and managing FC. It also highlights that butyrate's effect on enteric neurons is concentration-dependent, meaning both insufficient and excessive levels may be relevant to disease mechanisms.

What was studied?

This study examined how the gut microbiota changes with age and how those age-related changes relate to colorectal cancer (CRC). The researchers analyzed 11 metagenomic data sets, correcting for batch effects, then compared species composition and abundance across three age groups in both healthy individuals and CRC samples. They used LEfSe analysis to identify bacteria whose relative abundance differed by age group, then built age-prediction and CRC-risk-prediction models from those age-differentiated species.

Who was studied?

The abstract does not report a single original cohort with a specific sample size. Instead, the study population consisted of previously published metagenomic samples drawn from 11 combined data sets accessed through the curatedMetagenomicData R package, covering both healthy individuals and people with colorectal cancer. These samples were stratified into three age groups for comparison.

What were the most important findings?

The structure and composition of the gut microbiota differed significantly across the three age groups in both healthy and CRC samples. Bacteroides vulgatus abundance was lower in the older group compared to the other two groups, while Bacteroides fragilis abundance increased with aging. The researchers also identified seven bacterial species whose abundance rose with age, and found that abundance of pathogenic bacteria, including Escherichia coli, increased as well.

What are the greatest implications of this study?

By linking specific age-associated shifts in gut microbiota, such as declining Bacteroides vulgatus and rising Bacteroides fragilis and Escherichia coli, to both healthy aging and CRC samples, this work suggests the microbiome could serve as a biomarker for biological aging and CRC risk. The construction of age-prediction and CRC-risk-prediction models based on these age-differentiated bacteria points toward potential microbiota-based tools for estimating cancer risk as people age. This approach could inform future screening or risk-stratification strategies that account for age-related microbial changes.

What was studied?

Health disparities are driven by underlying social disadvantage and psychosocial stressors. However, how social disadvantage and psychosocial stressors lead to adverse health outcomes is unclear, particularly when exposure begins prenatally. Variations in the gut microbiome and circulating proinflammatory cytokines offer potential mechanistic pathways. Here, we interrogate the gut microbiome of mother-child dyads to compare high-versus-low prenatal social disadvantage, psychosocial stressors and maternal circulating cytokine cohorts (prospective case-control study design using gut microbiomes from 121 dyads profiled with 16 S rRNA sequencing and 89 dyads with shotgun metagenomic sequencing). Gut microbiome characteristics significantly predictive of social disadvantage and psychosocial stressors in the mothers and children indicate that different discriminatory taxa and related pathways are involved, including many species of Bifidobacterium and related pathways across several comparisons. The lowest inter-individual gut microbiome similarity was observed among high-social disadvantage/high-psychosocial stressors mothers, suggesting distinct environmental exposures driving a diverging gut microbiome assembly compared to low-social disadvantage/low-psychosocial stressors controls (P = 3.5 × 10-5 for social disadvantage, P = 2.7 × 10-15 for psychosocial stressors). Children's gut metagenome profiles at 4 months also significantly predicted high/low maternal prenatal IL-6 (P = 0.029), with many bacterial species overlapping those identified by social disadvantage and psychosocial stressors. These differences, based on maternal social and psychological status during a critical developmental window early in life, offer potentially modifiable targets to mitigate health inequities.

What was studied?

This study used metagenomic sequencing to characterize the gut microbiota of patients with non-segmental vitiligo. Researchers examined microbial community composition, diversity, and gene functions using bioinformatic analysis. They also predicted gut metabolic modules with the KEGG and MetaCyc databases to identify functional differences linked to the disease.

Who was studied?

The study enrolled 25 patients with non-segmental vitiligo and 25 matched healthy controls. All 50 participants underwent metagenomic sequencing of their gut microbiota for comparison between the two groups.

What were the most important findings?

Alpha diversity of the gut microbiome was significantly reduced in vitiligo patients compared with healthy controls. At the species level, Staphylococcus thermophiles was decreased while Bacteroides fragilis was increased in patients with vitiligo. LEfSe analysis identified additional microbial markers distinguishing vitiligo patients, including Lachnospiraceae_bacterium_BX3, Massilioclostridium_coli, and TM7_phylum_sp_oral_taxon_348, alongside Bacteroides_fragilis.

What are the greatest implications of this study?

These findings support a link between altered gut microbial composition and non-segmental vitiligo, reinforcing gut dysbiosis as a feature of the disease. The reduced diversity and specific species shifts, particularly the increase in Bacteroides fragilis, may serve as microbial markers for further investigation. Characterizing associated gene functions and metabolic modules could help clarify mechanisms connecting gut microbiota to vitiligo pathogenesis.

What was studied?

This study examined whether changes in the gut microbiome over time are linked to improvement in liver stiffness in people with nonalcoholic steatohepatitis (NASH). Researchers used 16S rRNA gene sequencing to profile gut microbial communities at baseline and again after 24 weeks of study participation. Liver stiffness was measured using magnetic resonance (MR) elastography, and the investigators compared microbial shifts in participants whose liver stiffness measurement (LSM) improved against those whose did not. They also looked at whether microbial changes tracked with secondary outcomes, including reduction in MRI-derived liver fat (MRI-PDFF) and regression of fibrosis on biopsy.

Who was studied?

The cohort consisted of 69 adults with biopsy-confirmed NASH and significant fibrosis (stages 2 to 3), enrolled in a multi-center randomized controlled trial evaluating the drug selonsertib alone or combined with simtuzumab. For comparison, fecal samples were also collected from 32 healthy adults. Genus-level multidimensional scaling was used to see whether microbial changes in the NASH participants who improved resembled the composition seen in this healthy comparison group.

What were the most important findings?

The abundance of 36 bacterial taxa shifted differently between participants with and without longitudinal improvement in liver stiffness. Lactobacillus showed a notably large decrease in participants with LSM improvement (log2 fold change of about -4.51, false discovery rate under 0.001), and Enterococcus was also among the taxa with altered abundance. These findings indicate that specific, identifiable shifts in gut bacterial composition accompany improvement in liver stiffness in NASH, rather than liver stiffness changing independently of the microbiome.

What are the greatest implications of this study?

By pairing longitudinal microbiome sampling with an objective, imaging-based measure of liver stiffness, this study strengthens the case for a mechanistic link between gut bacteria and NASH fibrosis trajectory. Identifying taxa such as Lactobacillus and Enterococcus as markers of improvement points toward candidate microbial signatures that could eventually help monitor or stratify NASH patients undergoing treatment. Because the design also compared shifts against a healthy reference cohort, the work lays groundwork for testing whether restoring a more typical gut microbial profile could be a therapeutic target in NASH, though this abstract does not itself establish causation.

What was studied?

This study investigated the connection between the oral and gut microbiome in Parkinson's disease (PD) using shotgun metagenomic sequencing. Researchers examined both the taxonomic composition and the functional gene content of these microbial communities. The aim was to determine whether oral microbiome changes relate to gut microbiome changes in PD, and whether these shifts produce functional alterations rather than just compositional differences.

Who was studied?

The abstract does not report specific sample sizes, ages, or recruitment details. The study compared PD patients to healthy controls, using paired oral and gut microbiome samples analyzed by shotgun metagenomic sequencing. Beyond the PD-versus-control design, no further cohort characteristics are given in the abstract.

What were the most important findings?

The taxonomic composition of both the oral and gut microbiome differed significantly between PD patients and healthy controls (P = 0.003 and 0.001, respectively). Oral Lactobacillus was more abundant in PD patients and was associated with opportunistic pathogens in the gut (FDR-adjusted P < 0.038). Functionally, microbial gene markers for glutamate and arginine biosynthesis were downregulated, while antimicrobial resistance gene markers were upregulated in PD patients compared to healthy controls (all P < 0.001).

What are the greatest implications of this study?

The findings suggest a connection between the oral and gut microbiota in PD that may drive functional, not just compositional, alterations of the microbiome. The rise in oral Lactobacillus alongside opportunistic gut pathogens points to the oral cavity as a potential contributor to gut dysbiosis in PD. Reduced glutamate and arginine biosynthesis and increased antimicrobial resistance gene markers highlight functional microbial pathways that may warrant further investigation as they relate to PD pathophysiology.

What was studied?

This single-center study profiled the gut mucosa-associated microbiome of Kenyan colorectal cancer (CRC) patients and healthy volunteers. Researchers used 16S rRNA sequencing to characterize microbial community composition, examining alpha and beta diversity, differential taxa abundance, and predicted microbial metabolic profiles. The study also evaluated associations between microbiome profiles and patient age, motivated by rising and increasingly early-onset CRC incidence in Kenya.

Who was studied?

The cohort consisted of 18 CRC patients and 18 healthy controls recruited at the Moi Teaching and Referral Hospital, Moi University, in Kenya. This population was chosen because microbiome studies in Kenyan CRC patients are rare, despite CRC incidence rates tripling in the country between 1997 and 2017. The hospital has also observed an increase in CRC diagnoses among younger patients.

What were the most important findings?

Alpha diversity did not differ significantly between CRC patients and healthy controls, but beta diversity metrics showed clear dissimilarities in overall microbial community structure between the two groups. The most notably underrepresented species in the CRC group were Prevotella copri and Faecalibacterium prausnitzii, an anti-inflammatory, butyrate-associated commensal. The abstract also points to an association with bacterial glutamate degradation pathways as part of the CRC-associated microbial signature.

What are the greatest implications of this study?

The findings suggest that gut microbiome dysbiosis, marked by loss of key commensals like Faecalibacterium prausnitzii and Prevotella copri, may contribute to CRC pathobiology in a Kenyan population that has been understudied in microbiome research. Because overall diversity was preserved while community composition shifted, compositional and functional changes rather than diversity loss appear more relevant to CRC in this setting. These results support further investigation of microbiome signatures, including glutamate metabolism pathways, as potential contributors to the rising and increasingly early-onset CRC burden in Sub-Saharan Africa.

What was studied?

This study examined the gut microbial composition and structure associated with colorectal cancer (CRC) across populations from different geographic regions. Researchers used whole-genome sequencing (WGS) data, annotated with MetaPhlAn2, to determine species and genus level relative abundance. They applied PCA and LEfSe analysis to compare microbial differences between regional datasets and used Spearman correlation analysis to examine relationships among CRC-associated differential species. The ultimate goal was to build and verify CRC risk prediction models based on these regional microbial differences.

Who was studied?

The analysis drew on a metagenomic dataset of 601 samples collected from six countries, sourced from the GMrepo and NCBI databases. This represents a secondary analysis of previously generated whole-genome sequencing data rather than a newly recruited clinical cohort. The abstract does not specify individual patient demographics such as age or sex, only the multi-country, multi-sample composition of the dataset.

What were the most important findings?

The composition of the intestinal bacterial community varied by region, and the specific differential intestinal bacteria linked to CRC were inconsistent from country to country. Despite this regional variability, the researchers identified a common diversity of bacteria shared across all six countries, including Peptostreptococcus. These findings indicate that CRC-associated microbiota show both a conserved core signature and considerable geographic variation.

What are the greatest implications of this study?

The findings suggest that CRC risk prediction models based on gut microbiota may need to account for regional differences in microbial composition rather than assuming a universal signature. Identifying bacteria that are consistently associated with CRC across diverse populations, such as Peptostreptococcus, could support more broadly generalizable diagnostic or risk-assessment tools. At the same time, the region-specific differences highlight the importance of validating any microbiome-based CRC model within the population it will be applied to.

What was studied?

This study examined the gut microbiota of patients with COVID-19 pneumonia using 16S rRNA gene sequencing performed on rectal swabs. Researchers compared microbial composition and diversity between patients treated in the intensive care unit (i-COVID19), patients treated in infectious disease wards (w-COVID19), and healthy controls (CTRL). The goal was to characterize how gut microbial communities differ across varying levels of COVID-19 disease severity.

Who was studied?

The study population consisted of patients hospitalized with COVID-19 pneumonia, divided into two groups by care setting: those admitted to the intensive care unit and those managed in infectious disease wards. These two patient groups were compared against a control group without COVID-19. The abstract does not report exact sample sizes, ages, or other demographic details for these cohorts.

What were the most important findings?

Patients in the ICU showed a decrease in the Chao1 index compared to both controls and ward patients, indicating lower microbial richness in the most severely ill patients, while the Shannon index showed no significant change. At the phylum level, ward patients showed an increase in Proteobacteria compared to controls. Fusobacteria and Spirochetes were both decreased relative to controls, with Spirochetes showing the greatest decrease in ICU patients specifically.

What are the greatest implications of this study?

The findings indicate that gut microbial communities shift in composition and richness according to COVID-19 disease severity, with the most pronounced changes occurring in critically ill ICU patients. These preliminary results suggest the gut microbiota may hold promising biomarkers for diagnosing COVID-19 and gauging disease severity. The authors note that validation in larger cohorts could support using microbiota profiles to help stratify patients by severity.

What was studied?

This study examined changes in intestinal bacterial communities across healthy people, patients with inflammatory bowel disease (IBD), and patients with colorectal cancer (CRC). The researchers performed metagenome-wide association studies on fecal samples to characterize bacterial community structure, relative abundance, and functional predictions. They also analyzed differentially abundant bacteria and co-occurrence networks to compare the three groups.

Who was studied?

The analysis drew on fecal metagenomic data from 290 healthy subjects, 512 IBD patients, and 285 CRC patients. Healthy and CRC data were obtained from the European Nucleotide Archive under several study accession numbers, while IBD patient data came from the Integrated Human Microbiome Project via the Human Microbiome Project Data Portal. This makes the cohort a large, multi-source pooled metagenomic dataset rather than a single newly recruited study population.

What were the most important findings?

The bacterial community structure in both IBD and CRC patients differed significantly from that of healthy subjects. Notably, IBD patients showed low intestinal bacterial diversity, while CRC patients showed high intestinal bacterial diversity, a contrasting pattern between the two disease states. The abstract does not specify Faecalibacterium prausnitzii, butyrate, or other named commensals, so no claim is made about those organisms here.

What are the greatest implications of this study?

The finding that IBD and CRC involve opposite directions of diversity change suggests these two diseases are associated with distinct, rather than uniform, disruptions of the gut microbiome. This distinction could help refine how metagenomic diversity and community structure are used to distinguish disease states from health and from each other. It also underscores the value of large, pooled public metagenomic datasets for characterizing disease-associated microbial signatures.

What was studied?

This study examined whether the intestinal microbiome influences clinical outcome and treatment side effects in early breast cancer. Researchers used shotgun metagenomics to characterize fecal microbiota composition and paired this with plasma metabolomics. They looked at associations between the gut microbiota, measured at baseline and after chemotherapy, and both breast cancer prognosis and therapy-induced side effects. Findings were then tested for clinical relevance in an immunocompetent mouse model colonized with patient microbiota and challenged with mouse breast cancer and chemotherapy.

Who was studied?

The human cohort consisted of 76 early breast cancer patients contributing 121 fecal specimens, with 45 patients providing paired samples collected before and after chemotherapy. These patients were enrolled in the CANTO prospective study, which was designed to record side effects associated with clinical management of breast cancer. The findings were further validated in immunocompetent mice colonized with breast cancer patient microbiota.

What were the most important findings?

Specific gut commensals were found to be overabundant in breast cancer patients compared with healthy individuals. These overabundant commensals were associated with worse breast cancer prognosis. Chemotherapy modulated the abundance of these gut microbes, and the same microbes appeared to influence weight gain and neurological side effects linked to breast cancer therapies.

What are the greatest implications of this study?

The results suggest that gut microbiota composition could serve as a modifiable factor affecting both cancer prognosis and treatment tolerability in early breast cancer. Because chemotherapy itself reshapes these microbial communities, monitoring or targeting the microbiome during treatment may offer a way to improve outcomes and reduce side effects. The authors note that these findings, obtained in adjuvant and neoadjuvant settings, warrant prospective validation before any clinical application.

What was studied?

The human oral and gut commensal microbes play vital roles in the development and maintenance of immune homeostasis, while its association with susceptibility and severity of SARS-CoV-2 infection is barely understood. In this study, we investigated the dynamics of the oral and intestinal flora before and after the clearance of SARS-CoV-2 in 53 COVID-19 patients, and then examined their microbiome alterations in comparison to 76 healthy individuals. A total of 140 throat swab samples and 81 fecal samples from these COVID-19 patients during hospitalization, and 44 throat swab samples and 32 fecal samples from sex and age-matched healthy individuals were collected and then subjected to 16S rRNA sequencing and viral load inspection. We found that SARS-CoV-2 infection was associated with alterations of the microbiome community in patients as indicated by both alpha and beta diversity indexes. Several bacterial taxa were identified related to SARS-CoV-2 infection, wherein elevated Granulicatella and Rothia mucilaginosa were found in both oral and gut microbiome. The SARS-CoV-2 viral load in those samples was also calculated to identify potential dynamics between COVID-19 and the microbiome. These findings provide a meaningful baseline for microbes in the digestive tract of COVID-19 patients and will shed light on new dimensions for disease pathophysiology, potential microbial biomarkers, and treatment strategies for COVID-19.

What was studied?

Accumulating evidence suggests that gut microbiota plays a role in the pathogenesis of schizophrenia via the microbiota-gut-brain axis. This study sought to investigate whether transplantation of fecal microbiota from drug-free patients with schizophrenia into specific pathogen-free mice could cause schizophrenia-like behavioral abnormalities. The results revealed that transplantation of fecal microbiota from schizophrenic patients into antibiotic-treated mice caused behavioral abnormalities such as psychomotor hyperactivity, impaired learning and memory in the recipient animals. These mice also showed elevation of the kynurenine-kynurenic acid pathway of tryptophan degradation in both periphery and brain, as well as increased basal extracellular dopamine in prefrontal cortex and 5-hydroxytryptamine in hippocampus, compared with their counterparts receiving feces from healthy controls. Furthermore, colonic luminal filtrates from the mice transplanted with patients' fecal microbiota increased both kynurenic acid synthesis and kynurenine aminotransferase II activity in cultured hepatocytes and forebrain cortical slices. Sixty species of donor-derived bacteria showed significant difference between the mice colonized with the patients' and the controls' fecal microbiota, highlighting 78 differentially enriched functional modules including tryptophan biosynthesis function. In conclusion, our study suggests that the abnormalities in the composition of gut microbiota contribute to the pathogenesis of schizophrenia partially through the manipulation of tryptophan-kynurenine metabolism.

What was studied?

This study examined whole metagenome sequences of cecum microbiomes from Ethiopian indigenous chickens raised at two different altitudes. Researchers compared microbial community composition, functional gene pathways, and antibiotic resistance gene abundance between the two locations. Functional profiling used the KEGG, eggNOG, and CAZy databases, and taxonomic differences were identified using LEfSe.

Who was studied?

The subjects were Ethiopian indigenous chickens sampled from two distinct geographical zones: the Afar district (Dulecha, 730 meters above sea level) and the Amhara district (Menz Gera Midir, 3300 meters above sea level). The abstract does not give an exact number of birds sampled, so the cohort is best described as cecum microbiome samples drawn from these two altitude-defined chicken populations.

What were the most important findings?

Cecum microbial populations in both groups were mainly dominated by Bacteroidetes and Firmicutes, and the two groups shared 2210 common genes. Coprobacter, Geobacter, Cronobacter, Alloprevotella, and Dysgonomonas were more abundant in the low-altitude Afar chickens than in the high-altitude Amhara chickens. Functional pathway analysis showed enrichment in metabolism, genetic information processing, environmental information processing, and cellular process categories, and this functional abundance was linked to nutrient absorption and microbial localization. Antibiotic resistance genes for LSM, cephalosporin, and tetracycline were significantly more abundant in the Afar (low-altitude) group than in the Amhara (high-altitude) group.

What are the greatest implications of this study?

The findings suggest that altitude and geographic location are associated with meaningful shifts in gut microbial composition, function, and antibiotic resistance gene burden in indigenous chickens. The higher abundance of resistance genes at lower altitude raises questions about environmental or management factors that could influence antibiotic resistance in poultry gut microbiomes. These results provide a baseline for understanding how environment shapes microbiome-linked traits relevant to poultry health and food safety in indigenous chicken populations.

What was studied?

This study examined whether gut microbiome composition, measured before treatment, is associated with response to immune checkpoint inhibitors in metastatic melanoma. Researchers used metagenomic shotgun sequencing on stool samples collected prior to treatment. The analysis specifically corrected for known confounders of gut microbiome composition, including age, BMI, and antibiotic use, which prior studies had often overlooked. Both taxonomic abundance and survival outcomes were assessed in relation to checkpoint inhibitor response.

Who was studied?

The study included 25 patients with unresectable metastatic melanoma who were treated with immune checkpoint inhibitors. Of these, 12 were classified as responders and 13 as non-responders. Pre-treatment stool samples were freshly frozen and analyzed from each of these patients.

What were the most important findings?

Alpha-diversity and overall bacterial prevalence did not differ significantly between responders and non-responders. However, after correcting for confounders in a zero-inflated multivariate analysis, 68 taxa showed differential abundance between the two groups. Carriership of Streptococcus parasanguinis was associated with longer overall survival, and carriership of Bacteroides massiliensis was associated with longer progression-free survival. In contrast, carriership of an unclassified Peptostreptococcaceae species was associated with shorter overall survival.

What are the greatest implications of this study?

The findings suggest that simple measures like overall diversity are insufficient to explain gut microbiome links to checkpoint inhibitor outcomes in melanoma, and that confounder-adjusted, species-level analysis reveals associations that broader measures miss. Identifying specific taxa tied to survival, such as Streptococcus parasanguinis and Bacteroides massiliensis, points to candidate biomarkers or mechanistic targets for future investigation. This approach, accounting for confounders like antibiotic use, age, and BMI, may help explain why prior studies lacked consensus on which taxa matter for treatment response.

What was studied?

Schizophrenia (SCZ) is a devastating mental disorder with poorly defined underlying molecular mechanisms. The gut microbiome can modulate brain function and behaviors through the microbiota-gut-brain axis. Here, we found that unmedicated and medicated patients with SCZ had a decreased microbiome α-diversity index and marked disturbances of gut microbial composition versus healthy controls (HCs). Several unique bacterial taxa (e.g., Veillonellaceae and Lachnospiraceae) were associated with SCZ severity. A specific microbial panel (Aerococcaceae, Bifidobacteriaceae, Brucellaceae, Pasteurellaceae, and Rikenellaceae) enabled discriminating patients with SCZ from HCs with 0.769 area under the curve. Compared to HCs, germ-free mice receiving SCZ microbiome fecal transplants had lower glutamate and higher glutamine and GABA in the hippocampus and displayed SCZ-relevant behaviors similar to other mouse models of SCZ involving glutamatergic hypofunction. Together, our findings suggest that the SCZ microbiome itself can alter neurochemistry and neurologic function in ways that may be relevant to SCZ pathology.

What was studied?

Checkpoint-blockade immunotherapy targeting programmed cell death protein 1 (PD-1) has recently shown promising efficacy in hepatocellular carcinoma (HCC). However, the factors affecting and predicting the response to anti-PD-1 immunotherapy in HCC are still unclear. Herein, we report the dynamic variation characteristics and specificities of the gut microbiome during anti-PD-1 immunotherapy in HCC using metagenomic sequencing.

What were the most important findings?

Fecal samples from patients responding to immunotherapy showed higher taxa richness and more gene counts than those of non-responders. For dynamic analysis during anti-PD-1 immunotherapy, the dissimilarity of beta diversity became prominent across patients as early as Week 6. In non-responders, Proteobacteria increased from Week 3, and became predominant at Week 12. Twenty responder-enriched species, including Akkermansia muciniphila and Ruminococcaceae spp., were further identified. The related functional genes and metabolic pathway analysis, such as carbohydrate metabolism and methanogenesis, verified the potential bioactivities of responder-enriched species.

What are the greatest implications of this study?

Gut microbiome may have a critical impact on the responses of HCC patients treated with anti-PD-1 immunotherapy. The dynamic variation characteristics of the gut microbiome may provide early predictions of the outcomes of immunotherapy in HCC, which is critical for disease-monitoring and treatment decision-making.

What was studied?

This study investigated the gut microbiome and metabolome in colorectal cancer (CRC) to test whether host-microbiome associations found in prior research, mostly from developed countries, also hold in a distinct population. Researchers performed metagenomic and metabolomic analyses of fecal samples, then compared their results with CRC microbiome data available from other populations. The focus was on identifying bacterial taxa and metabolic pathways linked to CRC in a setting where the disease has historically been rare.

Who was studied?

The study analyzed fecal samples from 30 colorectal cancer patients and 30 healthy controls recruited from two different locations in India. This population was chosen specifically because India has a low incidence of colorectal cancer and a distinct diet, lifestyle, and gut microbiome compared to other global populations. Data from this Indian cohort were also compared against previously published CRC microbiome datasets from other countries.

What were the most important findings?

The researchers confirmed that Bacteroides and other bacterial taxa already linked to CRC in earlier studies were also associated with CRC in this Indian cohort. A novel finding was the association of Flavonifractor plautii, a flavonoid-degrading bacterium, with CRC in these patients. This association correlated with enzymes and metabolic modules involved in flavonoid degradation, suggesting a link between the breakdown of beneficial anticarcinogenic flavonoids and the disease. The team also identified 20 potential microbial taxonomic markers and 33 potential microbial gene markers that distinguished CRC from healthy microbiomes with high accuracy using machine learning.

What are the greatest implications of this study?

The findings suggest that loss of beneficial, flavonoid-degrading control (via F. plautii) may contribute to cancer progression in this Indian cohort, expanding the known microbial players beyond previously identified taxa like Bacteroides. Because India has unusually low CRC incidence alongside a distinct gut microbiome, these cohort-specific biomarkers may not generalize globally and highlight the need for population-specific microbiome research. The taxonomic and gene markers identified could also support development of noninvasive, microbiome-based diagnostic tools for CRC in diverse populations.

What was studied?

This study examined gut microbiota composition in school-age children using 16S rRNA sequencing, comparing obese and normal-weight groups. Researchers looked for differences in bacterial taxa abundance and tested whether microbiota profiles were associated with serum amino acid levels and other obesity-related metabolic traits. Serum amino acids were measured by mass spectrometry to allow these correlations.

Who was studied?

The study included 67 normal-weight and 71 obese children aged 6 to 12 years in Mexico. This population was relevant given that childhood obesity is described as a serious public health problem in the country. The sample allowed direct comparison of gut microbiota and metabolic traits between weight groups within the same age range.

What were the most important findings?

Overall phyla abundances and Firmicutes/Bacteroidetes ratios did not differ significantly between obese and normal-weight children. However, Bacteroides eggerthii was significantly more abundant in obese children and correlated positively with body fat percentage and negatively with insoluble fibre intake. Bacteroides plebeius and unclassified Christensenellaceae were both significantly higher in normal-weight children, and abundance of these taxa correlated negatively with phenylalanine serum levels.

What are the greatest implications of this study?

The findings suggest that in children, obesity-associated microbiota shifts may be more evident at the species level than through broad phylum ratios like Firmicutes/Bacteroidetes. The association of Christensenellaceae and Bacteroides plebeius with normal weight and lower phenylalanine levels points to a possible link between specific gut taxa, amino acid metabolism, and leanness in children. These results support further investigation into specific bacterial species and their metabolic byproducts as potential markers or targets related to childhood obesity.

What was studied?

This study examined how gut microbiota respond to a short-term, self-directed personalized diet intervention. Researchers compared the effects of long-term dietary habits versus a brief two-week dietary change on gut community structure. Stool samples were analyzed using 16S rRNA sequencing before and after the intervention to detect shifts in microbial composition. The work aimed to clarify how the duration of a diet change relates to its impact on the gut microbiome.

Who was studied?

The study involved 248 citizen-science volunteers who participated in a self-reported, uncontrolled two-week personalized diet intervention. Participants provided stool samples both before and after the intervention, and their long-term dietary habits and lifestyle information were also collected. This was a citizen-science cohort rather than a tightly controlled clinical trial population.

What were the most important findings?

Long-term dietary habits correlated strongly with overall gut community structure, and higher vegetable and fruit intake was linked to more butyrate-producing Clostridiales and greater community richness. Even the brief, uncontrolled two-week intervention produced substantial changes in community structure, including decreased Bacteroidaceae, Porphyromonadaceae and Rikenellaceae and reduced alpha-diversity. This shift was accompanied by increases in Methanobrevibacter, Bifidobacterium, Clostridium and butyrate-producing Lachnospiraceae, along with a change in the prevalence of a permatype (a bootstrapping-based variant of enterotype). The abstract does not mention Desulfovibrio, sulfate-reducing bacteria, hydrogen sulfide, sulfide, or sulfur metabolism.

What are the greatest implications of this study?

The findings suggest that gut microbiota can shift meaningfully within just two weeks, even without tightly controlled dietary conditions. This implies that short, self-directed diet changes may be a practical lever for altering microbial composition, including beneficial shifts toward butyrate producers. The results also support the value of citizen-science approaches for studying personalized nutrition at scale. Both long-term dietary patterns and short-term interventions appear to matter for shaping the gut microbiome, suggesting they may act through different or complementary mechanisms.

What was studied?

The study investigated how fecal microbiota metabolize non-digestible oligo- and polysaccharides, using isothermal microcalorimetry to track fermentation in real time. Five substrates were tested: raffinose, melibiose, an oligo- and polysaccharide mixture produced from raffinose by levansucrase, levan synthesized from raffinose, and levan from timothy grass. Growth was assessed from heat evolution curves along with organic acid and gas production, and taxonomic shifts were profiled by 16S rDNA sequencing.

Who was studied?

The work used pooled fecal samples as inocula rather than individual human subjects tested directly. Three fecal pools were compared: one from overweight children, one from normal-weight children, and one from healthy adult volunteers. A pure culture of Bacteroides thetaiotaomicron was included as a reference colon bacterium alongside these pooled samples.

What were the most important findings?

Raffinose and melibiose promoted bifidobacteria growth across all three fecal pools, but each pool showed distinct additional responses. In the overweight children's pool, lactate-producing bacteria such as Streptococcus and Enterococcus became enriched, making lactic acid the dominant fermentation product from the short saccharides. In the normal-weight children's pool, acetic and butyric acids predominated instead, coinciding with enrichment of Catenibacterium, while in the adult pool the levans specifically promoted Bacteroides and Lachnospiraceae.

What are the greatest implications of this study?

The findings indicate that fecal microbiota from overweight versus normal-weight children ferment the same prebiotic-type substrates into different metabolic end products, not just different taxa. Because overweight children's microbiota favored lactic acid production over the acetate and butyrate seen in normal-weight children, substrate choice and host metabolic status together shape fermentation outcomes. This suggests that prebiotic selection may need to be tailored by weight status or metabolic phenotype rather than applied uniformly across pediatric populations.

What was studied?

This study examined the association between gut microbiota composition and Helicobacter pylori-related gastric lesions in a population at high risk for gastric cancer. Researchers used deep sequencing of the microbial 16S ribosomal RNA gene in fecal samples to characterize gut bacterial communities. The work was motivated by concern that H. pylori eradication, while effective for gastric cancer prevention, may carry adverse consequences such as microbial dysbiosis.

Who was studied?

The study included 47 subjects from a high-risk population for gastric cancer. Participants were grouped by H. pylori infection status (negative, past infection, or current infection) and by gastric lesion category, including normal, gastritis, and metaplasia. Fecal samples from these subjects were used for the microbiota analysis.

What were the most important findings?

Bacteroidetes, Firmicutes, and Proteobacteria dominated the fecal microbiota, with average relative abundances of 54.77%, 31.37%, and 12.91% respectively. Microbial diversity, measured by observed species and the Shannon index, was higher in subjects with past or current H. pylori infection than in H. pylori-negative subjects. Bacteroidetes abundance significantly decreased from H. pylori-negative subjects (66.16%) to those with past infection (33.01%), and also declined progressively from normal (76.49%) to gastritis (56.04%) to metaplasia (46.83%). Firmicutes and Proteobacteria showed elevated trends in the past infection group compared with the negative group, though these differences did not reach statistical significance.

What are the greatest implications of this study?

The findings suggest that H. pylori infection history and the severity of associated gastric lesions are linked to measurable shifts in gut bacterial diversity and composition, particularly reductions in Bacteroidetes. This raises the possibility that gut microbial dysbiosis accompanies both H. pylori infection and its downstream gastric pathology, which is relevant to concerns about consequences of eradication therapy. The results support further investigation into how gut microbiota patterns might serve as markers or contributors to gastric lesion progression in high-risk populations.

What was studied?

Age-related macular degeneration (AMD) is the most frequent cause of blindness in the elderly. There is evidence that nutrition, inflammation and genetic risk factors play an important role in the development of AMD. Recent studies suggest that the composition of the intestinal microbiome is associated with metabolic diseases through modulation of inflammation and host metabolism. To investigate whether compositional and functional alterations of the intestinal microbiome are associated with AMD, we sequenced the gut metagenomes of patients with AMD and controls. The genera Anaerotruncus and Oscillibacter as well as Ruminococcus torques and Eubacterium ventriosum were relatively enriched in patients with AMD, whereas Bacteroides eggerthii was enriched in controls. Patient's intestinal microbiomes were enriched in genes of the L-alanine fermentation, glutamate degradation and arginine biosynthesis pathways and decreased in genes of the fatty acid elongation pathway. These findings suggest that modifications in the intestinal microbiome are associated with AMD, inferring that this common sight threatening disease may be targeted by microbiome-altering interventions.

What was studied?

This study examined how the gut microbiome and circulating serum metabolites differ between lean and obese individuals. Researchers used a metagenome-wide association study paired with serum metabolomics profiling to identify obesity-associated gut microbial species and link them to changes in blood metabolites. They further tested a specific microbial species, Bacteroides thetaiotaomicron, in mice to determine its direct effect on body weight and fat accumulation. The study also examined whether bariatric surgery could reverse the microbial and metabolic changes seen in obesity.

Who was studied?

The human portion of the study involved a cohort of lean and obese, young, Chinese individuals, though the abstract does not specify exact sample size. A subset of these obese individuals also underwent bariatric surgery as a weight-loss intervention, with pre- and post-surgery comparisons used to assess reversal of obesity-associated changes. In addition to the human cohort, the researchers used a mouse model to test the functional effects of B. thetaiotaomicron administration via gavage.

What were the most important findings?

The abundance of Bacteroides thetaiotaomicron, a glutamate-fermenting commensal, was markedly decreased in obese individuals and was inversely correlated with serum glutamate concentration. In mice, gavage with B. thetaiotaomicron reduced plasma glutamate concentration and alleviated diet-induced body-weight gain and adiposity. Weight-loss intervention by bariatric surgery partially reversed these obesity-associated microbial and metabolic alterations, including restoring B. thetaiotaomicron abundance and lowering elevated serum glutamate.

What are the greatest implications of this study?

These findings identify a previously unknown link between a specific gut commensal, circulating amino acid levels, and obesity. The inverse relationship between B. thetaiotaomicron and serum glutamate, confirmed functionally in mice, suggests this microbe helps regulate host metabolism through glutamate fermentation. The results suggest it may be possible to intervene in obesity by directly targeting the gut microbiota, offering a potential mechanistic target for future metabolic therapies.

What was studied?

This prospective study examined whether pretreatment gut microbiota and metabolites are associated with response to immune checkpoint inhibitor (ICT) therapy in metastatic melanoma. Patients were treated with ipilimumab, nivolumab, ipilimumab plus nivolumab (IN), or pembrolizumab (P), and response was assessed using Response Evaluation Criteria in Solid Tumors. The study combined metagenomic shotgun sequencing of gut microbiota with unbiased shotgun metabolomic profiling to identify features linked to therapy efficacy. It builds on preclinical work showing specific gut microbiota can promote melanoma regression in mice.

Who was studied?

The study included 39 metastatic melanoma patients treated with ICT regimens (ipilimumab, nivolumab, ipilimumab plus nivolumab, or pembrolizumab). The abstract does not provide further demographic details such as age, sex distribution, or geographic site. IN yielded 67% responses and 8% stable disease, while pembrolizumab achieved 23% responses and 23% stable disease among these patients.

What were the most important findings?

Across all therapy types, ICT responders were enriched for Bacteroides caccae in their gut microbiome. Among IN responders specifically, the microbiome was enriched for Faecalibacterium prausnitzii, Bacteroides thetaiotaomicron, and Holdemania filiformis, while pembrolizumab responders showed enrichment of Dorea formicogenerans. Unbiased shotgun metabolomics further revealed high levels of anacardic acid in ICT responders, linking a specific metabolite to treatment response.

What are the greatest implications of this study?

The findings suggest that specific gut bacteria, including the anti-inflammatory commensal Faecalibacterium prausnitzii, and metabolites such as anacardic acid may serve as pretreatment indicators of ICT response in melanoma. As a pilot study, the authors state that both additional confirmatory clinical studies and preclinical testing of these bacterial and metabolite associations are needed. If validated, these microbiota and metabolite signatures could inform patient selection or adjunct strategies to improve ICT efficacy, particularly for patients failing standard therapy.

What was studied?

It is increasingly recognized that microbes that reside in and on human body sites play major roles in modifying the pathogenesis of several diseases, including cancer. However, specific microbes or microbial communities that can be mechanistically linked to cervical carcinogenesis remain largely unexplored. The purpose of the study was to examine the association between cervical microbiota and high-grade cervical intraepithelial neoplasia (CIN 2+) in women infected with high-risk (HR) human papillomaviruses (HPV) and to assess whether the cervical microbiota are associated with oxidative DNA damage as indicated by the presence of cervical cells positive for 8-hydroxy-2'-deoxyguanosine. The study included 340 women diagnosed with CIN 2+ (cases) and 90 diagnosed with CIN 1 (non-cases). Microbiota composition was determined by Illumina sequencing of the 16S rRNA gene amplified from DNA extracted from cervical mucus samples. Measures of alpha/beta-diversity were not associated with either CIN severity or oxidative DNA damage. However, a cervical mucosal community type (CT) dominated by L. iners and unclassified Lactobacillus spp was associated with CIN 2+ (OR = 3.48; 95% CI, 1.27-9.55). Sequence reads mapping to Lactobacillaceae, Lactobacillus, L. reuteri, and several sub-genus level Lactobacillus operational taxonomic units were also associated with CIN 2+ when examined independently (effect size >2.0; P < 0.05). Our 16S rRNA sequencing results need confirmation in independent studies using whole-genome shotgun sequencing and that would allow sharpening the suggested associations at finer taxonomic levels. Our results provide little evidence that DNA oxidative damage mediates the effect of the microbiome on the natural history of HPV infection and CIN severity. Cancer Prev Res; 9(5); 357-66. ©2016 AACR.

What was studied?

This study examined whether the enteric virome, alongside the bacterial microbiome, contributes to HIV-associated immunodeficiency and gut disease. Researchers characterized viral and bacterial communities in stool to see how they relate to HIV infection, antiretroviral therapy (ART) status, and CD4 T cell counts. The goal was to determine whether virome alterations track with immune decline independent of treatment.

Who was studied?

The cohort consisted of Ugandan patients, including individuals without HIV infection and individuals with HIV infection who were either on ART or untreated. The abstract does not give an exact sample size or additional demographic detail. Findings are grouped by HIV status, treatment status, and peripheral CD4 T cell count level.

What were the most important findings?

Low peripheral CD4 T cell counts were associated with an expansion of enteric adenovirus sequences, and this pattern held regardless of ART treatment. Patients with lower CD4 counts also had a bacterial microbiome with reduced phylogenetic diversity and richness. Specific bacterial taxa showed differential abundance, notably an increase in Enterobacteriaceae, a group linked to inflammation.

What are the greatest implications of this study?

The findings suggest that immunodeficiency in progressive HIV infection is accompanied by coordinated shifts in both the enteric virome and bacterial microbiome, not bacterial changes alone. Because the adenovirus expansion occurred regardless of ART status, viral alterations may persist even in treated patients and could still contribute to gut dysfunction. These combined viral and bacterial changes may help drive AIDS-associated enteropathy and disease progression, pointing to the virome as an underexplored factor in HIV-related gut pathology.

What was studied?

This study examined whether the composition of the gut microbial community differs in children with early onset multiple sclerosis (MS) compared with children without autoimmune disease. Researchers profiled fecal bacterial community composition using 16S ribosomal RNA sequencing and used PICRUSt to predict the functional capacity of these communities. They also tested whether overall community diversity (beta diversity) or specific taxa abundance related to MS status or to immunomodulatory drug (IMD) exposure.

Who was studied?

The cohort consisted of 18 children with relapsing-remitting MS and 17 control children, matched for age and sex, seen at a University of California, San Francisco pediatric clinic. Participants were 18 years old or younger, with a mean age of 13 years (range 4 to 18). The MS cases were within 2 years of disease onset, had a short mean disease duration of 11 months (range 2 to 24), and about half had never been exposed to immunomodulatory drugs.

What were the most important findings?

Overall gut bacterial beta diversity was not significantly associated with MS status itself. However, beta diversity was significantly associated with immunomodulatory drug exposure (Canberra distance, P less than 0.02). Relative to controls, the MS cases showed a significant enrichment in relative abundance of certain taxa, though the abstract provided does not specify which organisms were enriched.

What are the greatest implications of this study?

The findings suggest that in early pediatric MS, treatment exposure may shape the gut microbiota community more strongly than disease status alone, at least at the level of overall community diversity. The detection of specific taxa enriched in MS cases points to potential microbial features worth further investigation as markers or contributors to disease. Because this is a small case-control study, these results should be viewed as hypothesis generating rather than definitive, and larger studies are needed to confirm which taxa are involved and how treatment affects microbiota findings.

What was studied?

This study examined how the gut microbiome changes along the colorectal adenoma-carcinoma sequence, the stepwise progression from benign polyps to invasive cancer. Researchers used a metagenome-wide association study (MGWAS) on stool samples to catalogue microbial genes, strains, and functional pathways at each stage. The goal was to identify which gut microbes and functions are specifically enriched in adenoma versus carcinoma, since colorectal cancer often develops slowly from these precursor polyps and the microbiota is thought to play a direct role in that process.

Who was studied?

The comparison groups were stool samples from patients with advanced adenoma, patients with carcinoma, and healthy control subjects. The abstract does not report specific sample sizes, ages, or geographic origin of the cohort. Beyond identifying these three clinical groups, the analysis also incorporated dietary risk-factor data, specifically relative intake of red meat versus fruits and vegetables.

What were the most important findings?

The MGWAS revealed distinct sets of microbial genes, strains, and functions that were enriched in the adenoma group and in the carcinoma group compared with healthy subjects, indicating that the gut microbiome shifts in a stage-specific way along this disease sequence. A risk-factor analysis linked higher intake of red meat relative to fruits and vegetables with the outgrowth of bacteria that may help create a more hostile, pro-carcinogenic gut environment. The abstract does not name specific taxa such as Bilophila, Desulfovibrio, or sulfate-reducing bacteria, nor does it mention hydrogen sulfide, bile acids, or taurine.

What are the greatest implications of this study?

By mapping microbial changes across the adenoma-carcinoma sequence, the findings support the idea that stool-based microbiome signatures could serve as biomarkers for early, non-invasive detection of colorectal adenoma or carcinoma. The diet-microbiome link suggests that dietary patterns high in red meat relative to plant foods may promote a gut microbial environment conducive to disease progression, pointing to a modifiable risk factor. Together, these results suggest faecal microbiome profiling could inform both earlier diagnosis and future microbiome-targeted treatment strategies for colorectal cancer.

What was studied?

This study examined the early development of the gut microbiome in young children carrying high genetic risk for type 1 diabetes (T1D). Researchers used high throughput 16S rRNA gene sequencing on monthly stool samples collected from 4 to 6 months of age until 2.2 years of age. The goal was to identify compositional changes in the gut microbiome that occur before children develop T1D related autoimmunity. Both low abundance taxa and highly abundant groups, including two closely related Bacteroides species, were assessed for their relationship to later seroconversion.

Who was studied?

The cohort consisted of 76 children at high genetic risk for T1D, all born in the same hospital in Turku, Finland. Of these children, 29 later seroconverted to T1D related autoimmunity, and 22 of those went on to develop T1D, forming the case group. The remaining 47 children stayed healthy throughout the study period and served as controls.

What were the most important findings?

Several low abundance bacterial species showed significant compositional differences between children who later seroconverted and those who remained healthy. Notably, a highly abundant group made up of two closely related species, Bacteroides dorei and a related Bacteroides species, stood out as dominant in the gut microbiome prior to the onset of autoimmunity. This finding points to an early, high abundance microbial signal associated with the path toward T1D related autoimmunity, distinct from the more subtle low abundance differences.

What are the greatest implications of this study?

The early presence and dominance of Bacteroides dorei before autoimmune seroconversion suggests the gut microbiome may play an active role in the processes leading to T1D in genetically susceptible children. Because the sampling began in infancy and continued monthly, these findings support the idea that microbiome monitoring during early childhood could help identify children at elevated risk before clinical autoimmunity appears. This work adds to the broader case that environmental factors, particularly the developing gut microbiome, interact with genetic predisposition to influence autoimmune disease risk. The Salmonella and Enterobacteriaceae groups were not mentioned in this abstract, so no claims are made about them here.

What was studied?

This study examined how diet shapes gut microbial composition by comparing the fecal microbiota of children eating different diets. Researchers used high-throughput 16S rDNA sequencing together with biochemical analyses to characterize bacterial community composition and short-chain fatty acid output. The design set a fiber-rich, agrarian-style diet against a modern European diet to test whether microbiota differ along with dietary pattern.

Who was studied?

The study compared fecal samples from European children (EU) with those from children living in a rural African village in Burkina Faso (BF). The BF children's diet was high in fiber content and described as similar to the diet of early human settlements around the birth of agriculture. Exact sample sizes are not given in the abstract, but the comparison was structured as two defined pediatric cohorts, one European and one rural Burkinabe.

What were the most important findings?

BF children showed significant enrichment in Bacteroidetes and depletion in Firmicutes compared to EU children (P < 0.001). BF children also had a unique abundance of Prevotella and Xylanibacter, genera known to carry genes for cellulose and xylan hydrolysis, which were completely absent in EU children. BF children produced significantly more short-chain fatty acids than EU children (P < 0.001). Enterobacteriaceae, specifically Shigella and Escherichia, were significantly underrepresented in BF children relative to EU children (P < 0.05).

What are the greatest implications of this study?

The findings support the idea that gut microbiota coevolved with a polysaccharide-rich diet, helping BF children extract more energy from fiber through bacterial fermentation to short-chain fatty acids. The reduced abundance of Enterobacteriaceae, including Shigella and Escherichia, in the high-fiber BF group suggests diet may also influence the balance between beneficial fiber-degrading bacteria and potentially pathogenic Enterobacteriaceae. Together these results indicate that dietary pattern is a major driver of gut microbial ecology in children, with possible downstream effects on metabolic energy harvest and gut colonization resistance.